- “Today, companies have to realise that it’s not only about competing, but also about co-operating.” – Malvinder Singh, MD & CEO, Ranbaxy Laboratories
“The challenge in R&D is to keep people going on a project for 10 years and deciding if bonus is to be paid if it fails.” – Shiv Raman Dugal, Chairman, ICRI
“India’s current challenge in healthcare and research and development will be its future strength” – Ted Bianco, Director, Wellcome Trust
“We came to India looking for cheap hands, but after three years, we realise that we are staying here for the brains.” – Dr. Naveen Rao, Managing Director, Merck & Co, India
“Incremental research, reverse pharmacology and research in herbal products offer attractive opportunities” – Pratibha Pilgaonkar, CEO, Rubicon Research
“We have a drug offering a real possibility of eradicating Kala Azar, through public-private partnership” – Kavita Khanna, President, Bharat Serums & Vaccines
“India offers a fast track alternative to clinical R&D in traditional areas” – Anand Bidarkar, Vice- President, Siro Clinpharm
“Incremental innovation is better than NCE research, which is lengthy, risky and time consuming” – Dr. Ajit Dangi, President and CEO, Dansen Consulting
Wednesday, February 27, 2008
Quotes from Bio-Pharma Development Summit
Subscribe to:
Post Comments (Atom)
2 comments:
maET SUMMIT may provide spur to R&D based integration between private-public institutions. A strong interdisciplinary thinking within institute and without institute is need of day and cities like Delhi, Chandiagrh and Lucknow need to be made centre of 'research and development integration' through 'well understood and well designed policy framework' shared by both by state and Union government. This sharing should be translated in form of incentive to BIOPHARMA/BIOTECH PARKS on the tune of IT PARK.
In Hisar, a hub of 'Anibody based drugs' is being promoted at 'Knowledge Park, Hisar'. A plan to manufacture 'plantibody and plant-based vaccine' is being 'drafted'.
An international Conference on 'Immunobiological and Biopharmaceuticals' is being held in Feb 2009 and we would be thoroughly agreeing to work in a manner which ET Summit did.
This summit is for making 'animal healthcare affordable through biopharmaceuticals and production technologies like Embryo Transfer'.
Inputs are welcome and may contact Dr Jagveer Rawat at ficats@rediffmail.com or www.pie-forum.org
Jagveer Rawat
Joint Organising Secretary
International Symposium on 'Role of R&D in Veterinary Immunology and Biotechnology for affordable immunobiologicals and biopharmaceuticals'.
hey,
Ur post raises the questions that troubles most of the research students these days..But i must say that there are not many colleges that r of the caliber of ICRI. I think it is one of the best institutes of the country and with definite foreign recognition and bright future. The clinical research program is its speciality and has produced wonderful results for the country. I think that all the aspirants of research should take this college very seriously as it is a boon for their carrier. To apply to the college, just click on the following url...
http://tinyurl.com/6ellwe
Post a Comment